- Home
- TRNS vs DNTH Comparison
TRNS vs DNTH Comparison
Compare TRNS & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRNS
- DNTH
- Stock Information
- Founded
- TRNS 1964
- DNTH 2015
- Country
- TRNS United States
- DNTH United States
- Employees
- TRNS N/A
- DNTH N/A
- Industry
- TRNS Electrical Products
- DNTH Biotechnology: Pharmaceutical Preparations
- Sector
- TRNS Industrials
- DNTH Health Care
- Exchange
- TRNS Nasdaq
- DNTH Nasdaq
- Market Cap
- TRNS 748.7M
- DNTH 651.8M
- IPO Year
- TRNS N/A
- DNTH N/A
- Fundamental
- Price
- TRNS $90.43
- DNTH $24.30
- Analyst Decision
- TRNS Buy
- DNTH Strong Buy
- Analyst Count
- TRNS 4
- DNTH 8
- Target Price
- TRNS $108.67
- DNTH $54.00
- AVG Volume (30 Days)
- TRNS 86.3K
- DNTH 362.9K
- Earning Date
- TRNS 08-06-2025
- DNTH 08-07-2025
- Dividend Yield
- TRNS N/A
- DNTH N/A
- EPS Growth
- TRNS N/A
- DNTH N/A
- EPS
- TRNS 1.44
- DNTH N/A
- Revenue
- TRNS $288,138,000.00
- DNTH $4,854,000.00
- Revenue This Year
- TRNS $16.67
- DNTH N/A
- Revenue Next Year
- TRNS $9.14
- DNTH N/A
- P/E Ratio
- TRNS $62.37
- DNTH N/A
- Revenue Growth
- TRNS 8.49
- DNTH 17.87
- 52 Week Low
- TRNS $67.56
- DNTH $13.37
- 52 Week High
- TRNS $133.72
- DNTH $32.27
- Technical
- Relative Strength Index (RSI)
- TRNS 67.33
- DNTH 69.50
- Support Level
- TRNS $79.55
- DNTH $19.84
- Resistance Level
- TRNS $86.01
- DNTH $21.18
- Average True Range (ATR)
- TRNS 4.16
- DNTH 1.58
- MACD
- TRNS 1.12
- DNTH 0.39
- Stochastic Oscillator
- TRNS 99.08
- DNTH 89.88
About TRNS Transcat Inc.
Transcat Inc is involved in providing calibration and laboratory instrument services and distribution of test, measurement, and control instrumentation. Its product and services portfolio consists of calibration instruments, dimensional measuring tools, Electrical test instruments, pressure measurement, etc. The firm has Service and Distribution operating segments. It derives the majority of its revenues from the Service segment. The firm promotes and sells its products under brand names such as Estech, FLIR, Fluke, Keysight, and Megger among others. It serves to pharmaceutical, industrial manufacturing, energy, and chemical process industries.
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.